Culture Collections

General Cell Collection Detail

ECACC General Cell Collection: DMS 79

Supplied by: European Collection of Authenticated Cell Cultures (ECACC)
Culture Type: Cell line
Collection: ECACC General Collection
Catalogue No.: 95062824
Cell Line Name: DMS 79
Other Collection No.: ATCC CRL 2049
Citation Guidance: If use of this culture results in a scientific publication, it should be cited in the publication as: DMS 79 (ECACC 95062824)
Keywords: Human lung small cell carcinoma
Cell Line Description: DMS79 has been established from pleural fluid of a patient with small cell carcinoma of the lung. The patient was treated with cytoxan, vincristine, methotrexate and radiation therapy. The cultures show a tendency for the modal chromosome number to decline. The production of adrenocorticotropin (ACTH), bombesin, calcitonin, beta-endorphin, 17-beta-estradiol, lipotropin, ocytocin-neurophysin, parathyroid hormone and somatstatin-like imuno-reactivity has been reported. The cells have also been reported to have the following cell surface antigens: Leu-7, Class I HLA, Class II HLA, Mg23 defined by the AML-2-23 monoclonal antibody and the AML-1-99 defined antigen. The cells have a receptor for epidermal growth factor (EGF) and produce tumours in nude athymic mice. Cells grow as irregularly shaped aggregates.
Species: Human
Tissue of Origin: lung
CellType: Irregular
Growth Mode: Aggregates in suspension
DNA Profile: STR-PCR Data:

Amelogenin: X, Y
CSF1PO: 10
D13S317: 11
D16S539: 12
D5S818: 10
D7S820: 9,11
THO1: 8
vWA: 18

Karyotype: Aneuploid
Biosafety Information: Unless specified otherwise, at the European Collection of Authenticated Cell Cultures (ECACC) we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines. ACDP = Advisory Committee on Dangerous Pathogens (UK)
All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country.

ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises.

Hyperlinks to MSDS documents:
Frozen cell cultures Material Safety Data Sheet
Growing cell cultures Material Safety Data Sheet
Nucleic acids derived from cell cultures Material Safety Data Sheet
Subculture Routine: Maintain cultures between 3 - 9 x 100,000 cells/ml; 5% CO2; 37°C. Only dilute 1:2 as a maximum. This cell line grows as clumps in suspension which can be easily dispersed with pipetting. Trypsinisation is not necessary. Routine splitting can therefore be done by dilution. During acclimation to your laboratory , it is wise to count DMS 79 cells when cultures are split as there is apparent sensitivity to cell number.
Culture Medium: RPMI 1640 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS) (Heat Inactivated).
Depositor: Prof OS Pettengill and Prof. GD Sorenson, Dartmouth Medical School, Lebanon, NH
Originator: Yes
Country: USA
References: Cancer 1980;45:905
Additional Bibliography: Not specified
Patents: None specified by Depositor
Release Conditions: No

product documentsProduct Documents

Note: Links open in a new window

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.

Available Formats


Back to top
Copyright © Public Health England.

Please confirm your country of origin from the list below.